Clinical Trials Directory

Trials / Conditions / Locally Advanced/Metastatic Solid Tumors

Locally Advanced/Metastatic Solid Tumors

11 registered clinical trials studyying Locally Advanced/Metastatic Solid Tumors — 4 currently recruiting.

StatusTrialSponsorPhase
RecruitingCR-001 in Adult Participants With Locally Advanced or Metastatic Solid Tumors
NCT07335497
Crescent Biopharma, Inc.Phase 1 / Phase 2
RecruitingStudy of ESG406 in Adults With Solid Tumors
NCT06979674
Shanghai Escugen Biotechnology Co., LtdPhase 1
RecruitingStudy of ISM3412 in Participants With Locally Advanced/Metastatic Solid Tumors
NCT06414460
InSilico Medicine Hong Kong LimitedPhase 1
Active Not RecruitingA Study of FL115 Monotherapy in Unresectable or Metastatic Solid Tumors
NCT07131189
Suzhou Forlong Biotechnology Co., LtdPhase 1
CompletedFirst-in-Human, Phase I, Open-label, Multicenter, Dose Escalation Clinical Study
NCT06130722
Suzhou Forlong Biotechnology Co., LtdPhase 1
RecruitingPE0116 and PE0105 Injection in Treatment of Patients With Advanced Solid Tumor
NCT05801237
Shanghai HyaMab Biotech Co.,Ltd.Phase 1 / Phase 2
CompletedHY-0102 Monotherapy in Patients With Locally Advanced/Metastatic Solid Tumours
NCT04914351
Shanghai HyaMab Biotech Co.,Ltd.Phase 1
CompletedPE0116 Injection in Treatment of Patients With Advanced Solid Tumours
NCT05800249
Shanghai HyaMab Biotech Co.,Ltd.Phase 1
UnknownA Phase 1/2 Study of TY101 for Locally Advanced /Metastatic Solid Tumors and Relapsed or Refractory Lymphomas
NCT04458389
Tayu Huaxia Biotech Medical Group Co., Ltd.Phase 1 / Phase 2
UnknownSafety Study of BJ-001, an IL-15 Fusion Protein, for Locally Advanced/Metastatic Solid Tumors
NCT04294576
BJ Bioscience, Inc.Phase 1
CompletedA Phase I Study of MK-2206 in Combination With Standard Chemotherapy in Participants With Locally Advanced or
NCT00848718
Merck Sharp & Dohme LLCPhase 1